GDF-8

Clinical studies exploring the GDF8 peptide found that it can improve skeletal muscle mass and strength. This may have great significance to the numerous fields, such as sports performance, aging and muscle-wasting disease. During studies, general expression levels of both GDF8 and Myostatin were tested in muscle tissue which had been exposed to various treatments in vitro; while for their correlative expression analysis. They found that by blocking Myostatin, GDF-8 peptide may promote significant muscle hypertrophy. This could be beneficial to individuals living with conditions such as sarcopenia, cachexia or muscular dystrophy.

Increased skeletal muscle is associated with enhanced glucose regulation. As a result, increased muscle mass can effectively improve glucose regulation and reduce fat accumulation, which makes the GDF-8 peptide a potentially therapeutic treatment for obesity and type 2 diabetes.